Market Overview:
The global non-invasive glucose monitoring device market is expected to grow at a CAGR of 10.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in non-invasive glucose monitoring devices, and rising demand for home care settings. Based on type, the global non-invasive glucose monitoring device market is segmented into wearable devices and non-wearable devices. The wearable devices segment is further subsegmented into wristband monitors, smartwatch monitors, and implantable sensors. The wristband monitor segment accounted for the largest share of the global wearable devices market in 2017 owing to its low cost and easy availability compared with other types of wearable devices. Based on application, the global non-invasive glucose monitoring device market is divided into hospital settings, clinic settings, home care settings, and other applications (including research institutes/laboratories). In 2017, hospital settings accounted for the largest share of this market due to increasing number of patients with diabetes being admitted in hospitals for treatment purposes.
Product Definition:
A non-invasive glucose monitoring device is a medical device that can measure blood sugar levels without having to prick the skin. These devices are important for people with diabetes because they allow for more frequent blood sugar monitoring, which can help them better manage their diabetes.
Wearable Devices:
Wearable devices are small electronic devices that can be attached or integrated with the body for collecting physiological data. Technological advancements in the field of miniaturization and sensors have led to development of wearable devices. These wearables are used for monitoring various parameters such as blood pressure, heart rate, calorie intake, and calorie burn through continuous tracking and feedback mechanism.
Non-wearable Devices:
Non-wearable devices are used to measure blood sugar levels without the need for a needle. Technological advancements and increasing prevalence of diabetes are expected to drive the market over the forecast period.
Application Insights:
The hospital segment dominated the global market in 2017. The use of glucose monitors in hospitals has become common due to rising awareness about diabetes and increasing incidence of type 1 and type 2 patients. Furthermore, a rise in healthcare expenditure is expected to boost the demand for these devices over the forecast period.
The Clinic segment is anticipated to exhibit lucrative growth during the forecast period owing to growing awareness about diabetes among individuals at an early stage, thus resulting in increased demand for monitoring devices at an early stage as well as later stages of disease progression. In addition, technological advancements that have made it easier for patients with chronic diseases such as diabetes to use these devices are expected fuel industry growth over the next eight years.
The home care application segment accounted for USD 446 million share on account of high adoption rate among people suffering from chronic conditions such as heart diseases or kidney disorders associated with high blood pressure levels or proteinuria which require regular monitoring by medical professionals regarding their health condition related issues including medication adjustment.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing cases of diabetes, rising adoption of smart devices by patients, and high healthcare expenditure in this region. In addition, technological advancements such as miniaturization and wireless connectivity are also contributing toward growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as growing population with obesity problems and diabetes type 2 (T2D), improving living standards leading to an increase in disposable income which will ultimately result into a rise in consumer awareness about T2D care management procedures at home setting thus boosting demand for NGM systems for self-monitors or home settings.
Growth Factors:
- Increasing prevalence of diabetes and other chronic diseases: The global prevalence of diabetes is expected to reach 793 million by 2030. This will create a large pool of patients who will require regular monitoring of blood glucose levels, which in turn will drive the demand for non-invasive glucose monitoring devices.
- Technological advancements: Rapid advancements in technology are resulting in the development of more sophisticated and user-friendly non-invasive glucose monitoring devices. This is likely to boost the adoption rate of these devices among consumers.
- Growing awareness about the benefits of early diagnosis and treatment: There is growing awareness among people about the importance of early diagnosis and treatment for chronic diseases such as diabetes. This is likely to increase demand for non-invasive glucose monitoring devices in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-invasive Glucose Monitoring Device Market Research Report
By Type
Wearable Devices, Non-wearable Devices
By Application
Hospital, Clinic, Home Care, Other
By Companies
Abbott Laboratories, Cnoga Medical, Roche, Bayer Healthcare, Evia Medical, Integrity Applications, Nemaura Medical, Taiwan Biophotonic, RISE Life Science, MediWise, DexCom, Nova Biomedical, OrSense, Pendragon Medical, Cercacor
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Non-invasive Glucose Monitoring Device Market Report Segments:
The global Non-invasive Glucose Monitoring Device market is segmented on the basis of:
Types
Wearable Devices, Non-wearable Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Home Care, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Cnoga Medical
- Roche
- Bayer Healthcare
- Evia Medical
- Integrity Applications
- Nemaura Medical
- Taiwan Biophotonic
- RISE Life Science
- MediWise
- DexCom
- Nova Biomedical
- OrSense
- Pendragon Medical
- Cercacor
Highlights of The Non-invasive Glucose Monitoring Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Wearable Devices
- Non-wearable Devices
- By Application:
- Hospital
- Clinic
- Home Care
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-invasive Glucose Monitoring Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A non-invasive glucose monitoring device is a small, wearable device that measures blood sugar levels without having to prick the skin. These devices can be used to monitor blood sugar levels in people with diabetes or prediabetes, as well as people who are at risk for developing diabetes.
Some of the key players operating in the non-invasive glucose monitoring device market are Abbott Laboratories, Cnoga Medical, Roche, Bayer Healthcare, Evia Medical, Integrity Applications, Nemaura Medical, Taiwan Biophotonic, RISE Life Science, MediWise, DexCom, Nova Biomedical, OrSense, Pendragon Medical, Cercacor.
The non-invasive glucose monitoring device market is expected to grow at a compound annual growth rate of 10.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Non-invasive Glucose Monitoring Device Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Non-invasive Glucose Monitoring Device Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Non-invasive Glucose Monitoring Device Market - Supply Chain
4.5. Global Non-invasive Glucose Monitoring Device Market Forecast
4.5.1. Non-invasive Glucose Monitoring Device Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Non-invasive Glucose Monitoring Device Market Size (000 Units) and Y-o-Y Growth
4.5.3. Non-invasive Glucose Monitoring Device Market Absolute $ Opportunity
5. Global Non-invasive Glucose Monitoring Device Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Type
5.3.1. Wearable Devices
5.3.2. Non-wearable Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Non-invasive Glucose Monitoring Device Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Home Care
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Non-invasive Glucose Monitoring Device Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Non-invasive Glucose Monitoring Device Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Non-invasive Glucose Monitoring Device Demand Share Forecast, 2019-2026
9. North America Non-invasive Glucose Monitoring Device Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Home Care
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Type
9.7.1. Wearable Devices
9.7.2. Non-wearable Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Non-invasive Glucose Monitoring Device Demand Share Forecast, 2019-2026
10. Latin America Non-invasive Glucose Monitoring Device Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Home Care
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Type
10.7.1. Wearable Devices
10.7.2. Non-wearable Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Non-invasive Glucose Monitoring Device Demand Share Forecast, 2019-2026
11. Europe Non-invasive Glucose Monitoring Device Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Home Care
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Type
11.7.1. Wearable Devices
11.7.2. Non-wearable Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Non-invasive Glucose Monitoring Device Demand Share, 2019-2026
12. Asia Pacific Non-invasive Glucose Monitoring Device Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Home Care
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Type
12.7.1. Wearable Devices
12.7.2. Non-wearable Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Non-invasive Glucose Monitoring Device Demand Share, 2019-2026
13. Middle East & Africa Non-invasive Glucose Monitoring Device Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Home Care
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Non-invasive Glucose Monitoring Device Market Size and Volume Forecast by Type
13.7.1. Wearable Devices
13.7.2. Non-wearable Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Non-invasive Glucose Monitoring Device Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Non-invasive Glucose Monitoring Device Market: Market Share Analysis
14.2. Non-invasive Glucose Monitoring Device Distributors and Customers
14.3. Non-invasive Glucose Monitoring Device Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cnoga Medical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bayer Healthcare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Evia Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Integrity Applications
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Nemaura Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Taiwan Biophotonic
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. RISE Life Science
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. MediWise
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. DexCom
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Nova Biomedical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. OrSense
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Pendragon Medical
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Cercacor
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
